Ann: CRO APPOINTED FOR HEPATITIS C TRIAL , page-6

"Sounds like a company moving forward with clear direction and positivity."

I agree. The job of management in any company is to make these sorts of decisions. To go ahead with TT-034 is management having the courage of their convictions and hopefully they have picked the right path.

Personally, I would have preferred the trial to be in Europe and not the US and so I would have looked at a European CRO. Again this is the type of decision we pay management to make and they are aware of relevant information that the rest of us are not so, again, hopefully, they have made the right choice.

Time will tell but, in a few years time when we look back at this commitment, we will see this decision as a defining moment in the company's history. A make or break moment.

Go BLT, go!!!